$TSEMBullishMed

IQE And Tower Semiconductor Announce Multi-Year InP epiwafer Supply Agreement

IQE plc and Tower Semiconductor announced a multi-year agreement for Tower to buy Indium Phosphide (InP) epiwafers used in Tower’s silicon photonics platforms for AI data-center optical connectivity. The deal includes a minimum first-year purchase commitment and volume commitments thereafter, plus a worldwide royalty-free porous silicon patent license to settle prior IP litigation.

7/10
8/10
Med
Bullish
today’s PR announcement of a new multi-year supply agreement and IP settlement
risk-on for photonics supply-chain names; deal structure supports constructive sentiment

Securing a key InP epiwafer supply base for next-gen silicon photonics could support Tower’s roadmap execution and capacity planning.

Tower Semiconductor disclosed a multi-year InP epiwafer supply deal with IQE for silicon photonics platforms targeting 200G and prototyping 400G optical components.

Slight-to-moderate positive; may be viewed as strengthening supply chain for photonics growth, but magnitude is unclear without financial commitments.

Background

The release frames the agreement as supporting planned growth in InP silicon photonics for AI-driven data-center infrastructure, alongside resolving prior porous silicon IP disputes.

Why it matters

The deal provides minimum purchase commitment in year one and minimum volume commitments thereafter, plus a worldwide royalty-free patent license to IQE to settle litigation.

Market relevance

New multi-year supply and IP-settlement terms for InP epiwafers tied to 200G lane production and 400G modulator prototyping.

Market effects

Reinforces demand pull for InP epiwafers in AI data-center optical connectivity and next-gen pluggable transceivers/modulators.

Limited direct regional read-through; both parties are global suppliers with manufacturing footprints across Israel/US/Japan mentioned for Tower.

Supports the broader silicon photonics buildout narrative tied to hyperscale AI infrastructure scaling.

Alternative perspectives

Without disclosed financial terms (pricing, volumes beyond minimums, or ramp schedule), the market may discount the deal’s near-term earnings impact.

Execution risk remains (yield, qualification timelines for InP platforms, and whether minimum commitments translate into sustained share gains).

Key entities

  • IQE plc

    Supplier of compound semiconductor wafer products and advanced material solutions; will provide InP epiwafers to Tower’s photonics platforms.

  • Tower Semiconductor Ltd.

    Analog semiconductor foundry; will use IQE InP epiwafers in silicon photonics platforms and provides a royalty-free porous silicon patent license to IQE.

Related articles

$METAMed

Asian chip stocks slump as Meta plan spurs fears

Asian semiconductor shares fell after Bloomberg reported Meta Platforms is forming a business to monetize excess AI computing power, raising overcapacity fears. SK Hynix fell ~14% and Samsung ~9% in South Korea; Kioxia -13% and Tokyo Electron -7.4% in Japan; TSMC -1.6% in Taiwan; China tech gauge -7.7%. Meta’s plan could resemble AWS Bedrock and neocloud access.

$TSEMMed

Benzinga

Tower Semiconductor shares (NASDAQ: TSEM) rose in pre-market trading after the company and IQE disclosed a multi-year indium phosphide (InP) epiwafer supply agreement for AI-driven data center optical connectivity. The companies said they resolved all prior IP disputes. Tower shares were up 4.7% to $275.20 pre-market, according to Benzinga.

$TSEMMedAI 8/10

IQE and Tower Semiconductor Announce Multi-year InP epiwafer Supply Agreement

IQE and Tower Semiconductor announced a multi-year agreement for Tower to buy indium phosphide (InP) epiwafers for optical connectivity used in AI data-center infrastructure. IQE’s wafers will support Tower’s silicon photonics platforms, including 200Gb/s pluggable transceivers and prototyping 400Gb/s modulators. The companies also settled prior IP disputes via a worldwide, royalty-free porous silicon patent license.

$TSEMMed

Mon: TASE suffers biggest falls since October 8, 2023

Israel’s Tel Aviv Stock Exchange fell sharply after Iran halted talks with the US over escalation in Lebanon, according to the report. The Tel Aviv 35 Index dropped 4.21% to 4,268.02 and Tel Aviv 125 fell 4.31% to 4,239.39. Turnover was NIS 5.91b in equities and NIS 6.31b in bonds. Tower Semiconductor led losses (-13.99%).

$GSKMed

Hansoh Pharma: Phase III Trial For Ris-Rez Meets Primary Endpoint In China

Hansoh Pharmaceutical Group said its ARTEMIS-008 phase III trial of risvutatug rezetecan (Ris-Rez), a B7-H3 targeted ADC for advanced or relapsed small-cell lung cancer, met the primary endpoint of overall survival in China. GSK, which holds exclusive worldwide rights excluding China mainland, Hong Kong, Macau and Taiwan, said results support the target. GSK shares rose about 1% premarket to $53.01.

$AMDMed

AMD Ryzen AI Halo Review: Is $4K for Local AI Worth It?

AMD says it has started shipping the Ryzen AI Halo, a $3,999 mini PC with Ryzen AI Max+ 395 (Strix Halo), 128GB LPDDR5x, and 2TB NVMe, available with Windows 11 Pro or Linux at Micro Center. Reviews cited show NVIDIA’s DGX Spark at $4,699 is faster in prefill, while decode performance is closer. Key tradeoff is Windows support and networking.